Listen to a preview of Drugs, Devices or Data - Which is Most Valuable? Webcast

In an era where business-critical information is exchanged instantly, unsecured communication channels are a significant risk.

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

Making early commercial data and analytics decisions for launch cen future-proof their data management.

Market dynamics boost the need and urgency for more sophisticated benchmarking strategies.

EVERSANA’s chief digital officer discusses recent developments in the pharma industry that are impacting its relationship with patients and new technology.

Heather Gervais, CEO of Osso VR, discusses how technological advancements in VR are solving problems for pharmaceutical sales reps.